Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
MycoTechnology revenue
MycoTechnology's revenue is $2.6 million.
What is MycoTechnology's revenue?
- MycoTechnology has 82 employees, and the revenue per employee ratio is $31,707.
- MycoTechnology peak revenue was $2.6M in 2024.
On this page
Zippia finds jobs where you're a top candidate and applies on your behalf.
MycoTechnology financing
MycoTechnology received early financing of $215.0K on 2013-08-20.
| Series | Round size | Date |
|---|---|---|
| Debt Financing | $215K | 08/2013 |
| Debt Financing | $1M | 02/2014 |
| Debt Financing | $100K | 10/2014 |
| Series A | $9.2M | 10/2015 |
| Series B | $42M | 08/2017 |
| Series C | $30M | 01/2019 |
| Series D | $39M | 06/2020 |
| Series D | $1M | 11/2020 |
MycoTechnology investors
| Investors | Security type |
|---|---|
| GreatPoint Ventures | Series A |
| Wavemaker Partners | Series A |
| SEVENTURE PARTNERS | Series A |
| S2G Ventures | Series A |
| Closed Loop Capital | Series A |
| Middleland Capital | Series A |
| Tao Capital Partners | Series B |
| GreatPoint Ventures | Series B |
| Bunge | Series B |
| SEVENTURE PARTNERS | Series B |
| Touchdown Ventures | Series B |
| S2G Ventures | Series B |
| Closed Loop Capital | Series B |
| Middleland Capital | Series B |
| Eighteen94 Capital LLC | Series B |
| Ajinomoto Co Inc | Series B |
| Emerson Collective | Series B |
| Continental Grain Company | Series B |
| Health for Life Capital fund | Series B |
| Cibus Fund | Series C |
| Middleland MT Holdings | Series C |
| Bunge | Series C |
| TMI Investments BV | Series C |
| Continental Grain Company | Series C |
| Tyson Ventures | Series C |
| DNS-Hiitake | Series C |
| S2G Ventures | Series C |
| Eighteen94 Capital LLC | Series C |
| Evolution Capital Partners | Series D |
| Cibus Fund | Series D |
| Greenleaf Foods | Series D |
| Rich Products Ventures | Series D |
| Continental Grain Company | Series D |
| Tyson Ventures | Series D |
| SEVENTURE PARTNERS | Series D |
| S2G Ventures | Series D |
| Bunge Ventures | Series D |
| Middleland Capital | Series D |
| Eighteen94 Capital LLC | Series D |
| Gaingels | Series D |
| Radicle Growth | Series D |
| Syngenta Group | Series D |
Search for jobs
Most in demand jobs
Zippia gives an in-depth look into the details of MycoTechnology, including salaries, political affiliations, employee data, and more, in order to inform job seekers about MycoTechnology. The employee data is based on information from people who have self-reported their past or current employments at MycoTechnology. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by MycoTechnology. The data presented on this page does not represent the view of MycoTechnology and its employees or that of Zippia.
MycoTechnology may also be known as or be related to MycoTechnology, MycoTechnology Inc, MycoTechnology Inc. and MycoTechnology, Inc.